Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Methodology|Interests|Funding|Corrections
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Consultation record

Consultations on evaluation rubric documents

1 consultation on documents of this type.

All typesMethodology (3)Evaluation rubric (1)Methodological standard (18)Evidence synthesis (33)Compound monograph (51)Governance document (8)Document series (6)

Consultations

1 document
  • Draft supplier evaluation rubric
    CEI-CP-002ClosedEvaluation rubric06 Aug 2023 – 20 Sep 2023

    Consultation on the rubric by which the Institute assesses a supplier dossier. The rubric scores documentary and analytical practice; it does not score product quality, and the draft was released for comment principally because respondents…

    10 submissions2 not accepted
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.